Testing effectiveness (Phase 2)Study completedNCT01790100
What this trial is testing
A Phase 2a, Dose-Ranging Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C
Who this might be right for
Chronic Hepatitis C
Alios Biopharma Inc. 20